| Literature DB >> 29117910 |
Huan Huang1, Yuchao Jiang2, Mengqing Xia1, Yingying Tang3, Tianhong Zhang1, Huiru Cui1, Junjie Wang1, Yu Li1, Lihua Xu1, Adrian Curtin4, Jianhua Sheng1, Yuping Jia1, Dezhong Yao2, Chunbo Li5, Cheng Luo6, Jijun Wang7.
Abstract
Modified electroconvulsive therapy (MECT) has been widely applied to help treat schizophrenia patients who are treatment-resistant to pharmaceutical therapy. Although the technique is increasingly prevalent, the underlying neural mechanisms have not been well clarified. We conducted a longitudinal study to investigate the alteration of global functional connectivity density (gFCD) in schizophrenia patients undergoing MECT using resting state fMRI (functional magnetic resonance imaging). Two groups of schizophrenia inpatients were recruited. One group received a four-week MECT together with antipsychotic drugs (ECT+Drug, n=21); the other group only received antipsychotic drugs (Drug, n=21). Both groups were compared to a sample of healthy controls (HC, n=23). fMRI scans were obtained from the schizophrenia patients twice at baseline (t1) and after 4-week treatment (t2), and from healthy controls at baseline. gFCD was computed using resting state fMRI. Repeated ANCOVA showed a significant interaction effect of group×time in the schizophrenia patients in left precuneus (Pcu), ventral medial prefrontal cortex (vMPFC), and dorsal medial prefrontal cortex (dMPFC) (GRF-corrected P<0.05), which are mainly located within the default mode network (DMN). Post-hoc analysis revealed that compared with baseline (t1), an increased gFCD was found in the ECT+Drug group in the dMPFC (t=3.87, p=0.00095), vMPFC (t=3.95, p=0.00079) and left Pcu (t=3.33, p=0.0034), but no significant effect was identified in the Drug group. The results suggested that increased global functional connectivity density within the DMN might be one important neural mechanism of MECT in schizophrenia.Entities:
Keywords: Default mode network (DMN); Functional connectivity density (FCD); Modified electroconvulsive therapy (MECT); Schizophrenia
Mesh:
Substances:
Year: 2017 PMID: 29117910 DOI: 10.1016/j.schres.2017.10.044
Source DB: PubMed Journal: Schizophr Res ISSN: 0920-9964 Impact factor: 4.939